Výsledky vyhledávání - "Michael Tome"

Treatment results of brachytherapy vs. external beam radiation therapy for intermediate-risk prostate cancer with 10-year followup

Autor: Margaret S. Soper, Barry W. Goy, Jeff Slezak, Michael Tome, H. Cosmatos, Tangel Chang

Publikováno v: Brachytherapy. 15(6)

To compare 10-year treatment outcomes of brachytherapy vs. external beam radiation therapy for patients with intermediate-risk prostate cancer (IRPC).Between 2004 and 2007, 93 IRPC patients underwent brachytherapy using iodine-125 to a dose of 145 Gy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de18ff212a7551d564a0b6c0509e7ef3
https://pubmed.ncbi.nlm.nih.gov/27600607

Zobrazit plný text záznamu

A comparison of single-dose and fractionted total-body irradiation on the development of pneumonitis following bone marrow transplantation

Autor: Neil Kogut, Thomas L. Morgan, Kayur H. Shah, Michael Tome, Peter Falk, A. Robert Kagan

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 36:61-66

Purpose : A review of 132 consecutive patients who received bone marrow transplant for various malignancies was conducted to determine factors associated with increased risk in developing interstitial pneumonitis (IP) as the result of total body irra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2ab540231a027d2300bb3be419bb1d
https://doi.org/10.1016/s0360-3016(96)00246-5

Zobrazit plný text záznamu

Predicting pelvic lymph node involvement in current-era prostate cancer

Autor: Giatri Dave, Sophia Rahman, Stephen G. Williams, H. Cosmatos, Michael Tome

Publikováno v: International journal of radiation oncology, biology, physics. 82(2)

Purpose The Roach formula [2/3 × prostate-specific antigen + (Gleason score – 6) × 10], derived in 1993 during the early prostate specific antigen (PSA) screening era, has been used to predict the risk of pelvic lymph node involvement in patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49305fff418c138964b6123ec63a8d9
https://pubmed.ncbi.nlm.nih.gov/21300478

Zobrazit plný text záznamu

Treatment results of brachytherapy versus external beam radiation therapy for intermediate risk prostate cancer

Autor: Barry W. Goy, Margaret S. Soper, H. Cosmatos, Jeff Slezak, Michael Tome, Tangel Chang

Publikováno v: Journal of Clinical Oncology. 33:e16041-e16041

e16041 Background: The role of brachytherapy (BT) using Iodine-125 (I-125) without supplemental external beam radiation (EBRT) is usually limited to patients with low risk prostate cancer (PC). Our...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e495f8cf8f28fdec5d9fa6b23c8e8ec
https://doi.org/10.1200/jco.2015.33.15_suppl.e16041

Zobrazit plný text záznamu

Accelerated partial breast irradiation using the MammoSite device: early technical experience and short-term clinical follow-up

Autor: Peter I. Tsai, Kelly Meek, L. Andrew DiFronzo, Philip I. Haigh, Marianne Ryan, Jan K. Takasugi, Monica C. Ryoo, Michael Tome

Publikováno v: The American surgeon. 72(10)

The MammoSite brachytherapy system is a novel form of intracavitary accelerated partial breast irradiation (APBI) that allows treatment over a 5- to 7-day course after breast conserving surgery (BCS). Fifty-one patients with invasive breast carcinoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78695a42ebea0d01afc399a280b1aba
https://pubmed.ncbi.nlm.nih.gov/17058738

Zobrazit plný text záznamu

Treatment of T3 and T4 anal carcinoma with combined chemoradiation and interstitial 192Ir implantation: a 10-year experience

Autor: Ricardo Wang, Aroor R. Rao, H. Cosmatos, Julie M. Hwang, Jim Y. Hsiang, Michael Tome, John S. Kaptein, Robert Kagan

Publikováno v: Brachytherapy. 3(2)

Purpose To report our experience in treating T3 and T4 anal carcinoma with combined external beam (EBRT) and chemotherapy, followed by interstitial 192Ir implant boost. Methods and Materials From 1990 to 2000, 31 patients with T3 and T4 anal carcinom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1992e15dfa8204152b4cabbea4fd9fa
https://pubmed.ncbi.nlm.nih.gov/15374541

Zobrazit plný text záznamu

Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse

Autor: P.J. Anderson, Shahrokh Iganej, Michael Tome, Morteza Dowlatshahi, Robert Kagan, Ricardo Wang, Thomas L. Morgan, Aroor R. Rao, H. Cosmatos

Publikováno v: Headneck. 24(3)

Purpose Management of squamous cell carcinoma of undetermined primary tumors in the head and neck region is controversial. Here we report the Southern California Kaiser Permanente experience with these patients. Methods and Materials From January 196

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a189ade1cecd35f99a796b267a64be
https://pubmed.ncbi.nlm.nih.gov/11891955

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání